The Pharmaceutical Journal
Vol 275 No 7377 p654
26 November 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

NICE recommends SSRIs for obsessive-compulsive disorder

Selective serotonin reuptake inhibitors have been recommended as treatment for moderate obsessive-compulsive disorder (OCD) and for patients with milder OCD who decline or do not respond to psychological treatments.

In a clinical guideline issued this week, the National Institute for Health and Clinical Excellence recommends that cognitive behavioural therapy should be offered first line to patients with mild OCD. Advice on the management of body dysmorphic disorder is also included.